Table 1.
Variable | Intact nuclei | Condensed nuclei |
---|---|---|
+NGF | 100 | 2.0 ± 0.7 |
-NGF | 50 ± 3* | 4.5 ± 0.9* |
K-252a | 80 ± 2 | 3 ± 0.4 |
CEP | 78 ± 5 | 3 ± 0.8 |
K-252a/-NGF | 83 ± 7† | 2.5 ± 0.5† |
CEP/-NGF | 81 ± 4† | 2.0 ± 0.8† |
Two hours after incubation with K-252a (100 nM) and CEP-2563 (CEP) (200 nM), cells were washed 3 times and re-exposed for 24 h to a fresh medium with (K-252a; CEP) or without NGF (K-252a/-NGF; CEP/-NGF). The corresponding Western blot analysis showing the effect of TrkA inhibitors on TrkA(pY490) levels is reported in Fig. S2 a and b. Parallel experiments were performed with 10 μM Abeta 1-42 peptides in the presence or absence of K-252a and CEP-2563 (K-252a/Ab; CEP/Ab) (Fig. S2c and Table). Condensed nuclei are expressed as the mean ± SE of 10 fields of duplicate determinations of 5 independent experiments. Intact nuclei are reported as percentage of controls (+NGF).
*, P < 0.05 vs. cell survival of +NGF samples.
†, P < 0.05 vs. cell survival of -NGF or Abeta samples.